The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis

Journal of Neuroscience

Volumn 27, Issue 42, 2007, Pages 11228-11241

  Segura, Miguel F ^a   Sole, Carme ^a   Pascual, Marta ^c   Moubarak, Rana S ^b   Perez Garcia, M Jose ^a   Gozzelino, Raffaella ^a   Iglesias, Victoria ^b   Badiola, Nahuai ^b   Bayascas, Jose R ^a   Llecha, Nuria ^a   Rodriguez Alvarez, Jose ^b   Soriano, Eduardo ^c   Yuste, Victor J ^a   Comella, Joan X ^a,b  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; FAIM; Fas CD95; Neuron; Neurotrophic factor; TNF

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE 8; DEATH RECEPTOR; FAS ANTIGEN; FAS APOPTOSIS INHIBITORY MOLECULE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION;

EID: 35448996570     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3462-07.2007     Document Type: Article

References (64)

1. Ackery A, Robins S, Fehlings MG (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 23:604-616.
2. Arce V, Pollock RA, Philippe JM, Pennica D, Henderson CE, deLapeyriere O (1998) Synergistic effects of Schwann- and muscle-derived factors on motoneuron survival involve GDNF and cardiotrophin-1 (CT-1). J Neurosci 18:1440-1448.
3. Bayascas JR, Yuste VJ, Sole C, Sanchez-Lopez I, Segura MF, Perera R, Comella JX (2004) Characterization of splice variants of human caspase-activated DNase with CIDE-N structure and function. FEBS Lett 566:234-240.
4. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F (1999) FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27:62-74.
5. Beier CP, Wischhusen J, Gleichmann M, Gerhardt E, Pekanovic A, Krueger A, Taylor V, Suter U, Krammer PH, Endres M, Weller M, Schulz JB (2005) FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35. J Neurosci 25:6765-6774.
6. Bette M, Kaut O, Schafer MK, Weihe E (2003) Constitutive expression of p55TNFR mRNA and mitogen-specific up-regulation of TNF alpha and p75TNFR mRNA in mouse brain. J Comp Neurol 465:417-430.
7. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798.
8. Casha S, Yu WR, Fehlings MG (2005) Fas deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 196:390-400.
9. Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299-309.
10. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC (1999) Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-κB. J Neurosci 19:1754-1770.
11. Choi C, Benveniste EN (2004) Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 44:65-81.
12. Comella JX, Sanz-Rodriguez C, Aldea M, Esquerda JE (1994) Skeletal muscle-derived trophic factors prevent motoneurons from entering an active cell death program in vitro. J Neurosci 14:2674-2686.
13. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
14. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA, Walczak H, Falk W, Essig M, Edler L, Krammer PH, Martin-Villalba A (2004) Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 10:389-395.
15. Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369-377.
16. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5:118-125.
17. Endres R, Hacker G, Brosch I, Pfeffer K (2003) Apparently normal tumor necrosis factor 1 signaling in the absence of the silencer of death domains. Mol Cell Biol 23:6609-6617.
18. Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR (2001) FGF induces a switch in death receptor pathways in neuronal cells. J Neurosci 21:4996-5006.
19. Fernández M, Segura MF, Sole C, Colino A, Comella JX, Ceña V (2007) Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment. J Neurochem 103:190-203.
20. Gerhardt E, Kugler S, Leist M, Beier C, Berliocchi L, Volbracht C, Weller M, Bahr M, Nicotera P, Schulz JB (2001) Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis. Mol Cell Neurosci 17:717-731.
21. Graham EM, Sheldon RA, Flock DL, Ferriero DM, Martin LJ, O'Riordan DP, Northington FJ (2004) Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis 17:89-98.
22. Harlow DL (1988) Antibodies: a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
23. Iglesias M, Segura MF, Comella JX, Olmos G (2003) Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44:482-492.
24. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
25. Jiang Y, Woronicz JD, Goeddel DV (1999) Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283:543-546.
26. Kovac AD, Grammig J, Mahlo J, Steiner B, Roth K, Nitsch R, Bechmann I (2002) Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice. Eur J Neurosci 16:159-163.
27. Liston P, Young SS, Mackenzie AE, Korneluk RG (1997) Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2:423-441.
28. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279:32869-32881.
29. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809-3817.
30. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, Krammer PH (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679-686.
31. Mielke K, Herdegen T (2002) Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFalpha-mediated apoptosis in neuronlike, but not naive, PC12 cells. Mol Cell Neurosci 20:211-224.
32. Mobley WC, Schenker A, Shooter EM (1976) Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 15:5543-5552.
33. Nadeau S, Rivest S (1999) Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge. J Neuropathol Exp Neurol 58:61-77.
34. Naldini L, Blomer U, Gage FH, Trono D, Verma IM (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382-11388.
35. Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA (2002) Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a ρ-dependent mechanism. J Neurosci 22:854-862.
36. Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T (2003) Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab Invest 83:1033-1043.
37. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, Yonehara S (1998) Expression of fas antigen in the normal mouse brain. Biochem Biophys Res Commun 252:623-628.
38. Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, Johnson Jr EM (2002) Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J Cell Biol 157:441-453.
39. Raoul C, Henderson CE, Pettmann B (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol 147:1049-1062.
40. Raoul C, Pettmann B, Henderson CE (2000) Active killing of neurons during development and following stress: a role for p75(NTR) and Fas? Curr Opin Neurobiol 10:111-117.
41. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B (2002) Motoneuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-1083.
42. Raoul C, Buhler E, Sadeghi C, Jacquier A, Aebischer P, Pettmann B, Henderson CE, Haase G (2006) Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc Natl Acad Sci USA 103:6007-6012.
43. Rickle A, Behbahani H, Ankarcrona M, Winblad B, Cowburn RF (2006) PTEN, Akt, and GSK3beta signalling in rat primary cortical neuronal cultures following tumor necrosis factor-alpha and trans-4-hydroxy-2-nonenal treatments. J Neurosci Res 84:596-605.
44. Schneider TJ, Fischer GM, Donohoe TJ, Colarusso TP, Rothstein TL (1999) A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med 189:949-956.
45. Schweitzer B, Suter U, Taylor V (2002) Neural membrane protein 35/Lifeguard is localized at postsynaptic sites and in dendrites. Brain Res Mol Brain Res 107:47-56.
46. Shin DH, Lee E, Kim HJ, Kim S, Cho SS, Chang KY, Lee WJ (2002) Fas ligand mRNA expression in the mouse central nervous system. J Neuroimmunol 123:50-57.
47. Sole C, Dolcet X, Segura MF, Gutierrez H, Diaz-Meco MT, Gozzelino R, Sanchis D, Bayascas JR, Gallego C, Moscat J, Davies AM, Comella JX (2004) The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kappa B signaling. J Cell Biol 167:479-492.
48. Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma IM (1999) LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci USA 96:12667-12672.
49. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
50. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE (2001) MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276:16484-16490.
51. Tran SE, Meinander A, Eriksson JE (2004) Instant decisions: transcription-independent control of death-receptor-mediated apoptosis. Trends Biochem Sci 29:601-608.
52. Tschopp J, Irmler M, Thome M (1998) Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10:552-558.
53. Tschopp J, Martinon F, Hofmann K (1999) Apoptosis: silencing the death receptors. Curr Biol 9:R381-R384.
54. Ugolini G, Raoul C, Ferri A, Haenggeli C, Yamamoto Y, Salaun D, Henderson CE, Kato AC, Pettmann B, Hueber AO (2003) Fas/tumor necrosis factor receptor death signaling is required for axotomy-induced death of motoneurons in vivo. J Neurosci 23:8526-8531.
55. Wen W, Sanelli T, Ge W, Strong W, Strong MJ (2006) Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor. Neurosci Res 55:87-95.
56. Wu S, Zhou L, Rose M, Xiao X, Graham SH (2004) c-FLIP-L recombinant adeno-associated virus vector infection prevents Fas-mediated but not nerve growth factor withdrawal-mediated cell death in PC12 cells. Brain Res Mol Brain Res 122:79-87.
57. Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK (2003) Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein. Endocrinology 144:623-630.
58. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12:633-642.
59. Yoshino Q, Matsumo H, Nakamura H, Yudoh K, Abe Y, Sawai T, Uzuki M, Yonehara S, Kimura T (2004) The role of Fas-mediated apoptosis after traumatic spinal cord. Spine 29:1394-1404.
60. Yuste VJ, Bayascas JR, Llecha N, Sanchez-Lopez I, Boix J, Comella JX (2001) The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells: disappearance of the caspase-activated DNase. J Biol Chem 276:22323-22331.
61. Yuste VJ, Sanchez-Lopez I, Sole C, Moubarak RS, Bayascas JR, Dolcet X, Encinas M, Susin SA, Comella JX (2005) The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis. J Biol Chem 280:35670-35683.
62. Zhong X, Schneider TJ, Cabral DS, Donohoe TJ, Rothstein TL (2001) An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol Immunol 38:65-72.
63. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
64. Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann N, Martinez A, del Rio JA, Soriano E, Vodrazka P, Kuner R, Groene HJ, Herr I, Krammer PH, Martin-Villalba A (2006) Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13:31-40.